The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Comparison of Glial Fibrillary Acidic Protein and Desmin Staining in Normal and Ccl4–Induced Fibrotic Rat Livers
Open accessAbstract
Fat–storing cells are the major producers of extracellular matrix in the liver. A good immunocytochemical marker is, however, still lacking for this cell type. Desmin, frequently used by most investigators, fails to stain many pericentral fat–storing cells in normal rat liver. The aim of the present study is to evaluate glial fibrillary acidic protein (GFAP) as an alternative marker of fat–storing cells. In normal rat liver, immunostaining of GFAP revealed numerous fat–storing cells with characteristic cytoplasmic extensions. Unlike desmin, which was preferentially expressed in periportal fat–storing cells, GFAP–positive fat–storing cells were distributed more evenly in the lobules. In a narrow periportal zone, however, GFAP–positive cells were occasionally absent. Dual GFAP/desmin staining revealed colocalization of these markers, but fat–storing cells positive only for GFAP or desmin were also present. Chronic carbon tetrachloride exposure induced a spatial change in the expression of GFAP and desmin. At 3 weeks, accumulation of GFAP/desmin double–positive cells was observed in developing fibrotic septa. At 8 weeks, the GFAP positivity in the septa persisted but became weak, while desmin expression became stronger. In contrast, the expression of GFAP within the lobule was gradually decreased as fibrosis progressed. We conclude that GFAP is expressed by a subpopulation of fat–storing cells, which differs partially from the population that expresses desmin. Because in normal rat liver desmin– negative fat–storing cells can be identified by GFAP staining and vice versa, dual GFAP/desmin staining allows more complete identification of fat–storing cells. In chronically injured liver, GFAP may not be as useful as in normal rat liver. The coexpression of GFAP/desmin in developing septa and the subsequent downregulation of GFAP in an advanced stage of fibrosis may reflect different stages of fat–storing cell activation. Further investigation is required to determine the functional significance of alteration of GFAP expression in fat–storing cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pekny, M., Levéen, P., Pekna, M., Eliasson, C., Berthold, C. H., Westermark, B., & Betsholtz, C. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07147.x · Cited by 336
Cited by
Pathogenesis of liver fibrosis: role of oxidative stress
Poli, G. (2000) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00004-2 · Cited by 631
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers
Cassiman, D., Libbrecht, L., Desmet, V., Denef, C., & Roskams, T. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00260-4 · Cited by 410
Experimental models of liver fibrosis
Crespo Yanguas, S., Cogliati, B., Willebrords, J., Maes, M., Colle, I., van den Bossche, B., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A., Leclercq, I., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1543-4 · Cited by 350
Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
Li, D., & Friedman, S. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01928.x · Cited by 343
Levy, M. T., McCaughan, G. W., Abbott, C. A., Park, J. E., Cunningham, A. M., Müller, E., Rettig, W. J., & Gorrell, M. D. (1999) · Hepatology · doi:10.1002/hep.510290631 · Cited by 336
Metadata
- Authors
- Niki, T., De Bleser, P. J., Xu, G., Van der Berg, K., Wisse, E., & Geerts, A.
- Venue
- Hepatology
- Published
- 1996-06
- Volume
- 23
- Issue
- 6
- Pages
- 1538-1545
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2051906566
- Cited by
- 162
- References
- 1
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.